Guest guest Posted November 20, 2007 Report Share Posted November 20, 2007 > > Tigger, you might want to print this article out and give it to your doctor, it does help explain what goes on with us. In short, our brains lack the opioid receptors that 'normals' have. Here's a summary from the cited source: > > Decreased central mu-opioid receptor availability: reason of poor opioid response in fibromyalgia patients > 2007/11/02 > > The findings of a new study on the role of central mu-opioid receptors in fibromyalgia which were reported by Dr. E. and colleagues (Dept. of Internal Medicine, University of Michigan, Ann Arbor, MI) in the September issue of the Journal of Neuroscience, indicate an altered endogenous opioid analgesic activity in fibromyalgia. This may be a possible reason for why exogenous opiates have reduced efficacy in these patients. > > While neurophysiological mechanisms of acute pain have been fairly well characterized, the central mechanisms operative in chronic pain states are less well understood. Altered central neurotransmission is considered an underlying cause of one of the most common chronic pain condition, fibromyalgia (FM). This condition is characterized by widespread pain. > In the current study, the researchers included 17 FM patients and 17 age- and sex-matched healthy controls, and they compared both groups using positron emission tomography with a selective mu-opioid receptor (MOR) radiotracer. et al. demonstrated that FM patients display reduced MOR binding potential within several regions known to play a role in pain processing. These regions include the nucleus accumbens, the amygdala, and the dorsal cingulate. > MOR binding potential in the accumbens of FM patients was negatively correlated with affective pain ratings. Moreover, MOR binding potential throughout the cingulate and the striatum was also negatively correlated with the relative amount of affective pain within these patients - as assessed with the McGill pain questionnaire, affective score/sensory score. > Dr. stated that the decreased availability of the mu-opioid receptor which was more pronounced in patients reporting more pain, " may be due to fibromyalgia patients having fewer receptors and/or enhanced release of endogenous opioids. And he added, “one implication of this finding is that opiate drugs would not be very effective at reducing pain in these patientsâ€. > The research findings on mu-opioid receptor availability are clinically relevant, “because it has been difficult to determine the causes of pain in patients with fibromyalgia, to the point that acceptance of the condition by medical practitioners has been slow " . > > RE, Clauw DJ, DJ, et al.. Decreased central mu-opioid receptor availability in fibromyalgia. > > > > http://www.medpagetoday.com/Geriatrics/PainManagement/tb/6811 > > > > > Peace and Love > Caroline > > ____________________________________________________________ > ONE-CLICK WEBMAIL ACCESS - Easily monitor & access your email accounts! > Visit http://www.crawler.com/notifier and check it out! > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.